Promise of Real-World Evidence for Patient Centricity in Gulf Cooperation Council Countries: Call to Action.

Autor: Farghaly MNMH; Dubai Medical College, Dubai, United Arab Emirates.; DHIC, Dubai, United Arab Emirates., Al Ghaithi ISM; Consultant, Pediatric Hematology/Oncology, Royal Hospital, Muskat, Oman., Mahamid WAR; Heart and Vascular Institute Cleveland Clinic, Abu Dhabi, United Arab Emirates., Adlan A; Bioethics Saudi National Institute of Health Research Forum, Riyadh, Saudi Arabia., AlGhamdi SM; Applied Clinical Research, King Fahad Medical City, Riyadh, Saudi Arabia., Al Shammari TM; College of Pharmacy, Riyadh Elm University, Riyadh, Saudi Arabia.; King Saud University, Riyadh, Saudi Arabia., Alqahtani NM; Evidence Based Medicine Committee, Riyadh, Saudi Arabia., Al Ghnam SA; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia., Ibrahim MSA; Insights Research Organization & Solutions (IROS), Abu Dhabi, United Arab Emirates., Al Mudaiheem H; Ministry of Health, Riyadh, Saudi Arabia., Chouikrat MZ; Sanofi, Dubai, United Arab Emirates., Aktham Y; Sanofi, Jeddah, Kingdom of Saudi Arabia., El Bagoury ME; Sanofi, Dubai, United Arab Emirates., Gowda AJ; Principal, Management Consulting, AMESA, IQVIA, Bangalore, India. ajayaramegowda@in.imshealth.com., Al Moaikel K; RWE Kingdom of Saudi Arabia, IQVIA, Riyadh, Saudi Arabia., Abdallah NSA; Director, Commercial Offerings, ME, IQVIA, Dubai, United Arab Emirates.
Jazyk: angličtina
Zdroj: Drugs - real world outcomes [Drugs Real World Outcomes] 2023 Mar; Vol. 10 (1), pp. 1-9. Date of Electronic Publication: 2022 Nov 17.
DOI: 10.1007/s40801-022-00336-0
Abstrakt: Presently, Gulf Cooperation Council countries are lagging in the generation of real-world data and use of real-world evidence for patient-centered care compared with the global average. In a collaborative effort, experts from multiple domains of the healthcare environment from the Gulf Cooperation Council countries came together to present their views and recommended key action points for the generation of robust real-world data and leveraging real-world evidence in the countries. The opinions of the experts are presented, along with existing barriers to the effective generation of real-world evidence in the countries. The Gulf Cooperation Council countries are undergoing transformative changes paving the way for improved healthcare measures; however, the challenges in generating reliable, robust, accessible, and secure real-world evidence are persistent. Hence, ongoing public-private engagements, as well as collaborations between regulators, policymakers, healthcare professionals, insurance and pharmaceutical companies, and patients, are warranted. A few notable examples of real-world evidence studies highlighting the benefits of real-world evidence for gaining valuable insights into patient-centric decision making are also discussed. The actionable steps identified for successful real-world evidence generation would provide long-term, real-world evidence-based patient-centric benefits for the countries.
(© 2022. The Author(s).)
Databáze: MEDLINE
Externí odkaz: